AIxCrypto Holdings Reports Significant Growth Amid Transformation

AIxCrypto Holdings Inc., a U.S.-Nasdaq listed company, has made significant strides in transforming its business model from a clinical-stage biopharmaceutical company to an AI and blockchain-enabled digital infrastructure company. The company's full-year financial results for 2025 reveal the impact of this transformation on its financial performance.

In 2025, AIxCrypto Holdings Inc. underwent a strategic repositioning, including a $41 million private placement, rebranding from Qualigen Therapeutics Inc., and assembling an entirely new executive leadership team. This period was marked by significant capital formation and platform development, setting the stage for the company's future growth.

The company has announced plans to expand its Real-World Asset (RWA) product offerings, including scaling partnerships with Pinnacle Real Estate Group and advancing equity tokenization initiatives. With a focus on driving user scale, deepening application scenarios, and strengthening connections between physical and digital economies, AIxCrypto Holdings Inc. aims to establish itself as a leader in the intersection of AI, blockchain, and real-world industries.